Guideline-recommended doses of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs), and β blockers are similar for men and women with heart failure with reduced ejection fraction (HFrEF), even though there are known sex differences in pharmacokinetics of these drugs. We hypothesised that there might be sex differences in the optimal dose of ACE inhibitors or ARBs and β blockers in patients with HFrEF.
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study
Ravera A.Writing – Review & Editing
;Metra M.Membro del Collaboration Group
;
2019-01-01
Abstract
Guideline-recommended doses of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs), and β blockers are similar for men and women with heart failure with reduced ejection fraction (HFrEF), even though there are known sex differences in pharmacokinetics of these drugs. We hypothesised that there might be sex differences in the optimal dose of ACE inhibitors or ARBs and β blockers in patients with HFrEF.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Sex differences in HF medication 12sep2018 (003).doc
solo utenti autorizzati
Tipologia:
Full Text
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
961.5 kB
Formato
Microsoft Word
|
961.5 kB | Microsoft Word | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
